We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$58.4B
AUM Growth
+$3.16B
Cap. Flow
+$130M
Cap. Flow %
0.22%
Top 10 Hldgs %
22.35%
Holding
1,144
New
156
Increased
347
Reduced
289
Closed
87

Top Buys

Rank Stock Value
1
PCG icon
PG&E
PCG
+$395M
2
T icon
AT&T
T
+$334M
3
INTC icon
Intel
INTC
+$252M
4
WAB icon
Wabtec
WAB
+$225M
5
STLD icon
Steel Dynamics
STLD
+$224M

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$317M
2
PPG icon
PPG Industries
PPG
+$300M
3
BIDU icon
Baidu
BIDU
+$279M
4
CCK icon
Crown Holdings
CCK
+$227M
5
MSGS icon
Madison Square Garden
MSGS
+$219M

Sector Composition

Rank Sector Weight
1 Technology 16.17%
2 Communication Services 14.39%
3 Industrials 13.01%
4 Financials 11.45%
5 Healthcare 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMIH icon
726
NMI Holdings
NMIH
$3.34B
$326K ﹤0.01%
+19,189
New +$300K
PRGO icon
727
Perrigo
PRGO
$1.43B
$326K ﹤0.01%
+3,749
New +$322K
AMLP icon
728
Alerian MLP ETF
AMLP
$12.9B
$323K ﹤0.01%
6,000
AXS icon
729
AXIS Capital
AXS
$8.79B
$323K ﹤0.01%
6,435
-12,959
-67% -$690K
LOXO
730
DELISTED
Loxo Oncology, Inc
LOXO
$323K ﹤0.01%
+3,843
New +$320K
NAV
731
DELISTED
Navistar International
NAV
$320K ﹤0.01%
+7,463
New +$310K
PTLA
732
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$320K ﹤0.01%
+6,586
New +$333K
CORT icon
733
Corcept Therapeutics
CORT
$10.1B
$314K ﹤0.01%
+17,422
New +$316K
EGIO
734
DELISTED
Edgio, Inc. Common Stock
EGIO
$311K ﹤0.01%
+1,768
New +$349K
AL
735
DELISTED
Air Lease Corp
AL
$305K ﹤0.01%
6,346
CHUBK
736
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$304K ﹤0.01%
+14,812
New +$314K
TRTN
737
DELISTED
Triton International Limited
TRTN
$300K ﹤0.01%
+8,016
New +$308K
ENV
738
DELISTED
ENVESTNET, INC.
ENV
$299K ﹤0.01%
+6,004
New +$311K
SP
739
DELISTED
SP Plus Corporation
SP
$295K ﹤0.01%
+7,972
New +$310K
DVYE icon
740
iShares Emerging Markets Dividend ETF
DVYE
$1.2B
$292K ﹤0.01%
7,000
BCE icon
741
BCE
BCE
$20.3B
$288K ﹤0.01%
6,000
GLPI icon
742
Gaming and Leisure Properties
GLPI
$13B
$284K ﹤0.01%
+7,700
New +$280K
RHI icon
743
Robert Half
RHI
$4.04B
$284K ﹤0.01%
5,130
MDLZ icon
744
Mondelez International
MDLZ
$80.2B
$281K ﹤0.01%
6,574
AVY icon
745
Avery Dennison
AVY
$12.9B
$279K ﹤0.01%
2,430
+43
+2% +$4.65K
IRM icon
746
Iron Mountain
IRM
$37.4B
$279K ﹤0.01%
+7,400
New +$294K
GEO icon
747
The GEO Group
GEO
$4.11B
$276K ﹤0.01%
+11,700
New +$297K
HAE icon
748
Haemonetics
HAE
$3.75B
$274K ﹤0.01%
+4,721
New +$249K
MPT
749
Medical Properties Trust
MPT
$2.89B
$274K ﹤0.01%
+19,900
New +$269K
NVCR icon
750
NovoCure
NVCR
$1.89B
$271K ﹤0.01%
+13,425
New +$259K

Similar funds

Lazard Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Lazard Asset Management held 1,144 positions worth $58.4B, up 5.7% from $55.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lazard Asset Management's Q4 2017 filing shows 156 new, 347 increased, 289 reduced and 87 closed positions. Its largest new stake was Sterling Bancorp: 7,076,120 shares worth $174M. The largest sale was Kellanova, an estimated $317M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Communication Services and Industrials.

  • Lazard Asset Management's largest Q4 2017 buy was Sterling Bancorp: 7,076,120 shares worth $174M.
  • Lazard Asset Management added most to PG&E in Q4 2017, an estimated $395M increase.
  • Lazard Asset Management's biggest Q4 2017 reduction was Kellanova, cutting an estimated $317M.
  • Lazard Asset Management fully exited Woodward in Q4 2017, selling an estimated $30.8M.
  • Lazard Asset Management's ten largest holdings make up 22% of its $58.4B portfolio in Q4 2017.
  • Lazard Asset Management opened 156 new positions and closed 87 in Q4 2017.
  • Lazard Asset Management's portfolio value rose 5.7% quarter-over-quarter to $58.4B.

Based on Lazard Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.